Overall, the prognosis of MIRM is good. Only 4% of patients required admission to intensive care. Eighty-one percent of MIRM patients recover completely. Overall mortality from MIRM is 3%. Importantly, these cases were reported in the 1940s, which was a pre-macrolide antibiotic era (erythromycin A was first used clinically in 1952).